[HTML][HTML] Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy

M Tomasetti, W Lee, L Santarelli, J Neuzil - Experimental & molecular …, 2017 - nature.com
Malignant progression is greatly affected by dynamic cross-talk between stromal and cancer
cells. Exosomes are secreted nanovesicles that have key roles in cell–cell communication …

[HTML][HTML] Understanding the central role of citrate in the metabolism of cancer cells and tumors: An update

P Icard, A Coquerel, Z Wu, J Gligorov, D Fuks… - International journal of …, 2021 - mdpi.com
Citrate plays a central role in cancer cells' metabolism and regulation. Derived from
mitochondrial synthesis and/or carboxylation of α-ketoglutarate, it is cleaved by ATP-citrate …

[HTML][HTML] Hypoxia inducible factors in hepatocellular carcinoma

C Chen, T Lou - Oncotarget, 2017 - ncbi.nlm.nih.gov
Hepatocellular carcinoma is one of the most prevalent and lethal cancers with limited
therapeutic options. Pathogenesis of this disease involves tumor hypoxia and the activation …

[HTML][HTML] Phosphoinositide 3-kinase signaling pathway in pancreatic ductal adenocarcinoma progression, pathogenesis, and therapeutics

D Murthy, KS Attri, PK Singh - Frontiers in physiology, 2018 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …

[HTML][HTML] Long non-coding RNA PVT1/miR-150/HIG2 axis regulates the proliferation, invasion and the balance of iron metabolism of hepatocellular carcinoma

Y Xu, X Luo, W He, G Chen, Y Li, W Li… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: To investigate the biological roles and underlying molecular mechanisms
of long non-coding RNA (lncRNA) PVT1 in Hepatocellular carcinoma (HCC). Methods: qRT …

Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma

J Dai, Q Huang, K Niu, B Wang, Y Li, C Dai… - Cancer …, 2018 - Wiley Online Library
Hepatocellular carcinoma (HCC) is the malignancy derived from normal hepatocytes with
increasing incidence and extremely poor prognosis worldwide. The only approved first‐line …

[HTML][HTML] Modified AS1411 aptamer suppresses hepatocellular carcinoma by up-regulating galectin-14

Y Cho, YB Lee, JH Lee, DH Lee, EJ Cho, SJ Yu… - PloS one, 2016 - journals.plos.org
Aptamers are small synthetic oligonucleotides that bind to target proteins with high
specificity and affinity. AS1411 is an aptamer that binds to nucleolin, which is overexpressed …

[HTML][HTML] A key driver to promote HCC: Cellular crosstalk in tumor microenvironment

P Liu, L Kong, Y Liu, G Li, J Xie, X Lu - Frontiers in oncology, 2023 - frontiersin.org
Liver cancer is the third greatest cause of cancer-related mortality, which of the major
pathological type is hepatocellular carcinoma (HCC) accounting for more than 90%. HCC is …

[HTML][HTML] Platelets and hepatocellular cancer: bridging the bench to the clinics

Q Lai, A Vitale, TM Manzia, FG Foschi, GB Levi Sandri… - Cancers, 2019 - mdpi.com
Growing interest is recently being focused on the role played by the platelets in favoring
hepatocellular cancer (HCC) growth and dissemination. The present review reports in detail …

Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma

X Wang, W Hassan, Q Jabeen, GJ Khan, F Iqbal - Cytokine, 2018 - Elsevier
The novelty of an effective therapeutic targeting for hepatocellular carcinoma (HCC) is
based on improved understanding of each component of tumor microenvironment (TME) …